GE HealthCare Technologies Inc. (GEHC)
82.00 USD -2.90 (-3.42%) Volume: 4.82M
GE HealthCare Technologies Inc.’s stock price stands at 82.00 USD, experiencing a dip of -3.42% this trading session, with a trading volume of 4.82M. Despite the current decline, GEHC’s YTD performance shows a positive trend with an increase of +6.48%.
Latest developments on GE HealthCare Technologies Inc.
GE HealthCare Technologies has been making significant moves in the market recently, with updates to their FY24 earnings guidance and a boost in dividend, as well as unveiling ambitious growth targets through 2028. The company reported steady growth in Q3 2024 during their earnings call, leading to positive feedback from experts like Jim Cramer who believes they will have a strong story to tell. GE HealthCare also saw an increase in their stock price after pricing a 13M share secondary offering. With key investors like Advisors Asset Management Inc. and Banque Cantonale Vaudoise increasing their positions in the company, it’s clear that confidence in GE HealthCare is growing. Additionally, partnerships like the one with Imaging Biometrics for distribution expansion and the innovative technology like Portrait Mobile for post-surgical monitoring efficiency are positioning GE HealthCare for accelerated growth in the coming years.
A look at GE HealthCare Technologies Inc. Smart Scores
Factor | Score | Magnitude |
---|---|---|
Value | 3 | |
Dividend | 2 | |
Growth | 3 | |
Resilience | 2 | |
Momentum | 3 | |
OVERALL SMART SCORE | 2.6 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
GE HealthCare Technologies has received a mixed outlook based on Smartkarma Smart Scores. While the company scored well in terms of value and growth, with scores of 3 out of 5 in both categories, its dividend and resilience scores were lower at 2 out of 5. Momentum also scored a 3 out of 5. This suggests that the company may have potential for growth and value, but investors should be mindful of its dividend and resilience factors.
GE HealthCare Technologies Inc. is a company that provides medical technology, pharmaceutical diagnostics, and digital solutions. They offer a range of equipment such as imaging, ultrasound, maternal, ventilator, and patient monitoring devices, as well as various solutions including performance management, cybersecurity, technical training, and clinical network solutions. With a mixed outlook based on Smartkarma Smart Scores, investors may want to carefully consider the company’s overall performance and potential for the future.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
π‘ Before itβs here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- β Unlimited Research Summaries
- β Personalised Alerts
- β Custom Watchlists
- β Company Analytics and News
- β Events & Webinars